Las respuestas que necesitas para guiar la desescalada antibiótica en el paciente crítico adulto.
DOI:
https://doi.org/10.30445/rear.v13i8.911Palabras clave:
Desescalada antibiótica, Paciente crítico, resistencia antimicrobianaResumen
A pesar de que la desescalada antibiótica es reconocida como un aspecto importante en los programas de administración de antimicrobianos hay escasa evidencia de cómo debe realizarse en las Unidades de Cuidados Críticos. La presente guía, realizada por expertos, pretende dar respuestas prácticas acerca de la misma.
Citas
- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 | SpringerLink [Internet]. [cited 2020 Feb 9]. Available from: https://link.springer.com/article/10.1007%2Fs00134-017-4683-6
- Tabah A, Cotta MO, Garnacho-Montero J, Schouten J, Roberts JA, Lipman J, et al. A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care Unit. Clin Infect Dis. 2016 Apr 15;62(8):1009–17.
- On behalf of the OUTCOMEREA Study Group, Weiss E, Zahar JR, Garrouste-Orgeas M, Ruckly S, Essaied W, et al. De-escalation of pivotal beta-lactam in ventilator-associated pneumonia does not impact outcome and marginally affects MDR acquisition. Intensive Care Med. 2016 Dec;42(12):2098–100.
- De Bus L, Denys W, Catteeuw J, Gadeyne B, Vermeulen K, Boelens J, et al. Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study. Intensive Care Med. 2016 Jun;42(6):1029–39.
- Gonzalez L, Cravoisy A, Barraud D, Conrad M, Nace L, Lemarié J, et al. Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patients. Crit Care Lond Engl. 2013 Jul 12;17(4):R140.
- Leone M, Bechis C, Baumstarck K, Lefrant J-Y, Albanèse J, Jaber S, et al. De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med. 2014 Oct 1;40(10):1399–408.
- Paul M, Dickstein Y, Raz-Pasteur A. Antibiotic de-escalation for bloodstream infections and pneumonia: systematic review and meta-analysis. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2016 Dec;22(12):960–7.
- López-Cortés LF, Rosso-Fernández C, Núñez Núñez M, Lavín-Alconero L, Bravo-Ferrer J, Barriga Á, et al. Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferiority clinical trial. 2017 [cited 2020 Feb 16]; Available from: https://digital.csic.es/handle/10261/180334
- Tabah A, Cotta MO, Garnacho-Montero J, Schouten J, Roberts JA, Lipman J, et al. A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care Unit. Clin Infect Dis. 2016 Apr 15;62(8):1009–17.
- On behalf of the OUTCOMEREA Study Group, Weiss E, Zahar JR, Garrouste-Orgeas M, Ruckly S, Essaied W, et al. De-escalation of pivotal beta-lactam in ventilator-associated pneumonia does not impact outcome and marginally affects MDR acquisition. Intensive Care Med. 2016 Dec;42(12):2098–100.
- De Bus L, Denys W, Catteeuw J, Gadeyne B, Vermeulen K, Boelens J, et al. Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study. Intensive Care Med. 2016 Jun;42(6):1029–39.
- Gonzalez L, Cravoisy A, Barraud D, Conrad M, Nace L, Lemarié J, et al. Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patients. Crit Care Lond Engl. 2013 Jul 12;17(4):R140.
- Leone M, Bechis C, Baumstarck K, Lefrant J-Y, Albanèse J, Jaber S, et al. De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med. 2014 Oct 1;40(10):1399–408.
- Paul M, Dickstein Y, Raz-Pasteur A. Antibiotic de-escalation for bloodstream infections and pneumonia: systematic review and meta-analysis. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2016 Dec;22(12):960–7.
- López-Cortés LF, Rosso-Fernández C, Núñez Núñez M, Lavín-Alconero L, Bravo-Ferrer J, Barriga Á, et al. Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferiority clinical trial. 2017 [cited 2020 Feb 16]; Available from: https://digital.csic.es/handle/10261/180334
Descargas
Publicado
2021-09-06
Cómo citar
Cifuentes García, B., Fernández Ruipérez, L., de Capadocia Rosell, J., & Jiménez Vizuete, J. M. (2021). Las respuestas que necesitas para guiar la desescalada antibiótica en el paciente crítico adulto. Revista Electrónica AnestesiaR, 13(8). https://doi.org/10.30445/rear.v13i8.911
Número
Sección
Comentarios de artículos
Licencia
Derechos de autor 2021 Revista Electrónica AnestesiaR
Esta obra está bajo una licencia internacional Creative Commons Atribución-CompartirIgual 4.0.
Envío y derechos de autor
Revista Electrónica AnestesiaR by 